280 Chapter 11 111. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. The New England journal of medicine. 2013;368(5):407-15. 112. Dondorp AM, Iyer SS, Schultz MJ. Critical Care in Resource-Restricted Settings. Jama. 2016;315(8):753-4. 113. Organization WH. The top 10 causes of death: World Health Organization; 2017 [17-12-2017]. The top 10 causes of death]. Available from: http://www.who.int/mediacentre/factsheets/ fs310/en/. 114. Austin S, Murthy S, Wunsch H, Adhikari NK, Karir V, Rowan K, et al. Access to urban acute care services in high- vs. middle-income countries: an analysis of seven cities. Intensive care medicine. 2014;40(3):342-52. 115. Collaborators GL. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet Infectious diseases. 2017;17(11):1133-61. 116. Adhikari NK, Fowler RA, Bhagwanjee S, Rubenfeld GD. Critical care and the global burden of critical illness in adults. Lancet (London, England). 2010;376(9749):1339-46. 117. Ashley EA, Lubell Y, White NJ, Turner P. Antimicrobial susceptibility of bacterial isolates from community acquired infections in Sub-Saharan Africa and Asian low and middle income countries. Trop Med Int Health. 2011;16(9):1167-79. 118. Alp E, Kiran B, Altun D, Kalin G, Coskun R, Sungur M, et al. Changing pattern of antibiotic susceptibility in intensive care units: ten years experience of a university hospital. Anaerobe. 2011;17(6):422-5. 119. Wiersinga WJ, van der Poll T, White NJ, Day NP, Peacock SJ. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol. 2006;4(4):272-82. 120. Schultz MJ, Dunser MW, Dondorp AM, Adhikari NK, Iyer S, Kwizera A, et al. Current challenges in the management of sepsis in ICUs in resource-poor settings and suggestions for the future. Intensive care medicine. 2017;43(5):612-24. 121. Reddy EA, Shaw AV, Crump JA. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. The Lancet Infectious diseases. 2010;10(6):417-32. 122. Esel D, Doganay M, Alp E, Sumerkan B. Prospective evaluation of blood cultures in a Turkish university hospital: epidemiology, microbiology and patient outcome. Clin Microbiol Infect. 2003;9(10):1038-44. 123. Papali A, McCurdy MT, Calvello EJ. A “three delays” model for severe sepsis in resourcelimited countries. Journal of critical care. 2015;30(4):861 e9-14. 124. Machado FR, Ferreira EM, Sousa JL, Silva C, Schippers P, Pereira A, et al. Quality Improvement Initiatives in Sepsis in an Emerging Country: Does the Institution’s Main Source of Income Influence the Results? An Analysis of 21,103 Patients. Critical care medicine. 2017;45(10):1650-9. 125. Serpa Neto A, Schultz MJ, Festic E. Ventilatory support of patients with sepsis or septic shock in resource-limited settings. Intensive care medicine. 2016;42(1):100-3. 126. Kwizera A, Festic E, Dunser MW. What’s new in sepsis recognition in resource-limited settings? Intensive care medicine. 2016;42(12):2030-3. 127. Musa N, Murthy S, Kissoon N. Pediatric sepsis and septic shock management in resourcelimited settings. Intensive care medicine. 2016;42(12):2037-9. 128. Thwaites CL, Lundeg G, Dondorp AM, sepsis in resource-limited settings-expert consensus recommendations group of the European Society of Intensive Care M, the Mahidol-Oxford Research Unit in Bangkok T. Recommendations for infection management in patients with sepsis and septic shock in resource-limited settings. Intensive care medicine. 2016;42(12):2040-2.
RkJQdWJsaXNoZXIy MTk4NDMw